Human Gene MIR124-1 (uc003wsw.1) Description and Page Index
  Description: Homo sapiens microRNA 124-1 (MIR124-1), microRNA.
RefSeq Summary (NR_029668): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: LM608483.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr8:9,760,898-9,760,982 Size: 85 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksGenetic AssociationsRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr8:9,760,898-9,760,982)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerHGNCLynxOMIM
PubMedStanford SOURCE

-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): MIR124-1
CDC HuGE Published Literature: MIR124-1

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 512.94 RPKM in Brain - Cerebellum
Total median expression: 1173.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  LF210124 - JP 2014500723-A/17627: Polycomb-Associated Non-Coding RNAs.
CS266388 - Sequence 80 from Patent WO2005118806.
CS266578 - Sequence 270 from Patent WO2005118806.
DL076550 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DL076740 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004200 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM004390 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM176434 - A nucleics Acid regulating cell growth.
FU261150 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763652 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV528008 - Nucleic acid controling mast cell degranulation.
FW421542 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421732 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HH932805 - Sequence 17 from Patent EP2239675.
HV304551 - JP 2009531018-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305049 - JP 2009531019-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV970130 - JP 2012523000-A/17: Method for in vitro Diagnosing a Complex Disease.
HW119258 - JP 2013046612-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367413 - JP 2012228254-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367603 - JP 2012228254-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411806 - JP 2014000079-A/80: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW411996 - JP 2014000079-A/270: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589587 - JP 2013121348-A/118: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674152 - JP 2014217381-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674342 - JP 2014217381-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ043186 - JP 2015510401-A/276: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ067094 - JP 2014012020-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067284 - JP 2014012020-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ081812 - JP 2015514392-A/276: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ408258 - JP 2015528002-A/855: CHIRAL CONTROL.
HZ413391 - JP 2014060993-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427518 - JP 2014217384-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427708 - JP 2014217384-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428321 - JP 2014217385-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428511 - JP 2014217385-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429124 - JP 2014217386-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429314 - JP 2014217386-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429927 - JP 2014217387-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430117 - JP 2014217387-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501602 - JP 2016025853-A/118: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769184 - JP 2014223080-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769374 - JP 2014223080-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058578 - Sequence 80 from Patent EP2298893.
JA058768 - Sequence 270 from Patent EP2298893.
JA059381 - Sequence 80 from Patent EP2298894.
JA059571 - Sequence 270 from Patent EP2298894.
JA073704 - Sequence 80 from Patent EP2281887.
JA073894 - Sequence 270 from Patent EP2281887.
JA104841 - Sequence 80 from Patent EP2302051.
JA105031 - Sequence 270 from Patent EP2302051.
JA106181 - Sequence 80 from Patent EP2302052.
JA106371 - Sequence 270 from Patent EP2302052.
JA106984 - Sequence 80 from Patent EP2302053.
JA107174 - Sequence 270 from Patent EP2302053.
JA107787 - Sequence 80 from Patent EP2302054.
JA107977 - Sequence 270 from Patent EP2302054.
JA108590 - Sequence 80 from Patent EP2302055.
JA108780 - Sequence 270 from Patent EP2302055.
JA109393 - Sequence 80 from Patent EP2302056.
JA109583 - Sequence 270 from Patent EP2302056.
JA191909 - Sequence 80 from Patent EP2290066.
JA192099 - Sequence 270 from Patent EP2290066.
JA192808 - Sequence 80 from Patent EP2290067.
JA192998 - Sequence 270 from Patent EP2290067.
JA193707 - Sequence 80 from Patent EP2290068.
JA193897 - Sequence 270 from Patent EP2290068.
JA194606 - Sequence 80 from Patent EP2290069.
JA194796 - Sequence 270 from Patent EP2290069.
JA195505 - Sequence 80 from Patent EP2290070.
JA195695 - Sequence 270 from Patent EP2290070.
JA196404 - Sequence 80 from Patent EP2290071.
JA196594 - Sequence 270 from Patent EP2290071.
JA197303 - Sequence 80 from Patent EP2290072.
JA197493 - Sequence 270 from Patent EP2290072.
JA198202 - Sequence 80 from Patent EP2290073.
JA198392 - Sequence 270 from Patent EP2290073.
JA199101 - Sequence 80 from Patent EP2290074.
JA199291 - Sequence 270 from Patent EP2290074.
JA200000 - Sequence 80 from Patent EP2290075.
JA200190 - Sequence 270 from Patent EP2290075.
JA200899 - Sequence 80 from Patent EP2290076.
JA201089 - Sequence 270 from Patent EP2290076.
JA218021 - Sequence 80 from Patent EP2281888.
JA218211 - Sequence 270 from Patent EP2281888.
JA226172 - Sequence 80 from Patent EP2292755.
JA226362 - Sequence 270 from Patent EP2292755.
JA229027 - Sequence 80 from Patent EP2292756.
JA229217 - Sequence 270 from Patent EP2292756.
JA257298 - Sequence 80 from Patent EP2284265.
JA257488 - Sequence 270 from Patent EP2284265.
JA278578 - Sequence 80 from Patent EP2281886.
JA278768 - Sequence 270 from Patent EP2281886.
JA284464 - Sequence 80 from Patent EP2281889.
JA284654 - Sequence 270 from Patent EP2281889.
JA292517 - Sequence 80 from Patent EP2287303.
JA292707 - Sequence 270 from Patent EP2287303.
JA317703 - Sequence 80 from Patent EP2314688.
JA317893 - Sequence 270 from Patent EP2314688.
JA374762 - Sequence 80 from Patent EP2322616.
JA374952 - Sequence 270 from Patent EP2322616.
JA525968 - Sequence 118 from Patent EP2369011.
JA526475 - Sequence 118 from Patent EP2369012.
JA526982 - Sequence 118 from Patent EP2369013.
JA535911 - Sequence 118 from Patent EP2371971.
JA787916 - Sequence 118 from Patent EP2479285.
JA788414 - Sequence 118 from Patent EP2479286.
JA810748 - Sequence 118 from Patent EP2468890.
JA811246 - Sequence 118 from Patent EP2468891.
JA811744 - Sequence 118 from Patent EP2468893.
JA812242 - Sequence 118 from Patent EP2468894.
JA812740 - Sequence 118 from Patent EP2468895.
JA813238 - Sequence 118 from Patent EP2468896.
JA813736 - Sequence 118 from Patent EP2468897.
JA814234 - Sequence 118 from Patent EP2468898.
JA814732 - Sequence 118 from Patent EP2468899.
JA816975 - Sequence 118 from Patent EP2468892.
JA825787 - Sequence 118 from Patent EP2471956.
JA826285 - Sequence 118 from Patent EP2471958.
JB024572 - Sequence 118 from Patent EP2505668.
JB025070 - Sequence 118 from Patent EP2505669.
JB079457 - Sequence 118 from Patent EP2487252.
JB079955 - Sequence 118 from Patent EP2487253.
JB080453 - Sequence 118 from Patent EP2487254.
JB080951 - Sequence 118 from Patent EP2487255.
JB081449 - Sequence 118 from Patent EP2487256.
JB081947 - Sequence 118 from Patent EP2487257.
JB082445 - Sequence 118 from Patent EP2487258.
JB082943 - Sequence 118 from Patent EP2487259.
JB083441 - Sequence 118 from Patent EP2487260.
JB083939 - Sequence 118 from Patent EP2487261.
JB084437 - Sequence 118 from Patent EP2487262.
JB084935 - Sequence 118 from Patent EP2487263.
JB087613 - Sequence 118 from Patent EP2502630.
JB147817 - Sequence 118 from Patent EP2484782.
JB148315 - Sequence 118 from Patent EP2484783.
JB153040 - Sequence 118 from Patent EP2514433.
JB153538 - Sequence 118 from Patent EP2514434.
JB622127 - Sequence 118 from Patent EP2586454.
JB622625 - Sequence 118 from Patent EP2586455.
JC001688 - Sequence 118 from Patent EP2591794.
JC221605 - Sequence 80 from Patent EP2471923.
JC221795 - Sequence 270 from Patent EP2471923.
JC268171 - Sequence 80 from Patent EP2471924.
JC268361 - Sequence 270 from Patent EP2471924.
JC340479 - Sequence 80 from Patent EP2471922.
JC340669 - Sequence 270 from Patent EP2471922.
JC469725 - Sequence 80 from Patent EP2471921.
JC469915 - Sequence 270 from Patent EP2471921.
JC990514 - Sequence 80 from Patent EP2808390.
JC990704 - Sequence 270 from Patent EP2808390.
LF128872 - JP 2016507218-A/3: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
LF404283 - JP 2015509366-A/276: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF714617 - JP 2016165292-A/80: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF714807 - JP 2016165292-A/270: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856551 - JP 2015142597-A/80: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LF856741 - JP 2015142597-A/270: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051592 - KR 1020150036642-A/858: CHIRAL CONTROL.
LP643472 - Sequence 1 from Patent WO2015041809.
LP909361 - Sequence 22 from Patent EP3214174.
LY505008 - KR 1020170032361-A/1: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
LZ228168 - JP 2017524341-A/26: HYBRID TRNA/PRE-MIRNA MOLECULES AND METHODS OF USE.
LZ229979 - JP 2017522313-A/1: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
MA353814 - JP 2018075017-A/276: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
FU261154 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763656 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304555 - JP 2009531018-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305053 - JP 2009531019-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119262 - JP 2013046612-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589591 - JP 2013121348-A/122: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413395 - JP 2014060993-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501606 - JP 2016025853-A/122: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA525972 - Sequence 122 from Patent EP2369011.
JA526479 - Sequence 122 from Patent EP2369012.
JA526986 - Sequence 122 from Patent EP2369013.
JA535915 - Sequence 122 from Patent EP2371971.
JA787920 - Sequence 122 from Patent EP2479285.
JA788418 - Sequence 122 from Patent EP2479286.
JA810752 - Sequence 122 from Patent EP2468890.
JA811250 - Sequence 122 from Patent EP2468891.
JA811748 - Sequence 122 from Patent EP2468893.
JA812246 - Sequence 122 from Patent EP2468894.
JA812744 - Sequence 122 from Patent EP2468895.
JA813242 - Sequence 122 from Patent EP2468896.
JA813740 - Sequence 122 from Patent EP2468897.
JA814238 - Sequence 122 from Patent EP2468898.
JA814736 - Sequence 122 from Patent EP2468899.
JA816979 - Sequence 122 from Patent EP2468892.
JA825791 - Sequence 122 from Patent EP2471956.
JA826289 - Sequence 122 from Patent EP2471958.
JB024576 - Sequence 122 from Patent EP2505668.
JB025074 - Sequence 122 from Patent EP2505669.
JB079461 - Sequence 122 from Patent EP2487252.
JB079959 - Sequence 122 from Patent EP2487253.
JB080457 - Sequence 122 from Patent EP2487254.
JB080955 - Sequence 122 from Patent EP2487255.
JB081453 - Sequence 122 from Patent EP2487256.
JB081951 - Sequence 122 from Patent EP2487257.
JB082449 - Sequence 122 from Patent EP2487258.
JB082947 - Sequence 122 from Patent EP2487259.
JB083445 - Sequence 122 from Patent EP2487260.
JB083943 - Sequence 122 from Patent EP2487261.
JB084441 - Sequence 122 from Patent EP2487262.
JB084939 - Sequence 122 from Patent EP2487263.
JB087617 - Sequence 122 from Patent EP2502630.
JB147821 - Sequence 122 from Patent EP2484782.
JB148319 - Sequence 122 from Patent EP2484783.
JB153044 - Sequence 122 from Patent EP2514433.
JB153542 - Sequence 122 from Patent EP2514434.
JB622131 - Sequence 122 from Patent EP2586454.
JB622629 - Sequence 122 from Patent EP2586455.
JC001692 - Sequence 122 from Patent EP2591794.
JB974703 - Sequence 14 from Patent EP2684962.
JC107388 - Sequence 14 from Patent WO2013175446.
CS083365 - Sequence 99 from Patent WO2005040419.
CS548258 - Sequence 1288 from Patent EP1777301.
DJ003745 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027024 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ061811 - Oligonucleotide Microarray.
DJ087825 - Novel miRNA molecules isolated from human embryonic stem cell.
DM119566 - Targeting Cells With Altered miRNA Expression.
FU261406 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763908 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV527637 - Nucleic acid controling mast cell degranulation.
FW311998 - DETECTING NUCLEIC ACIDS.
FZ415731 - JP 2010536372-A/11: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH.
HV304807 - JP 2009531018-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305305 - JP 2009531019-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV534416 - WO 2011111715-A/932: Nucleic acid for controlling cell cycle.
HV954035 - JP 2012518421-A/947: METHODS OF DETECTING LUNG CANCER.
HW119514 - JP 2013046612-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589843 - JP 2013121348-A/374: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ075001 - JP 2013535982-A/1092: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ075036 - JP 2013535982-A/1127: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ413647 - JP 2014060993-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501858 - JP 2016025853-A/374: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526224 - Sequence 374 from Patent EP2369011.
JA526731 - Sequence 374 from Patent EP2369012.
JA527238 - Sequence 374 from Patent EP2369013.
JA536167 - Sequence 374 from Patent EP2371971.
JA715165 - Sequence 947 from Patent EP2401406.
JA788172 - Sequence 374 from Patent EP2479285.
JA788670 - Sequence 374 from Patent EP2479286.
JA811004 - Sequence 374 from Patent EP2468890.
JA811502 - Sequence 374 from Patent EP2468891.
JA812000 - Sequence 374 from Patent EP2468893.
JA812498 - Sequence 374 from Patent EP2468894.
JA812996 - Sequence 374 from Patent EP2468895.
JA813494 - Sequence 374 from Patent EP2468896.
JA813992 - Sequence 374 from Patent EP2468897.
JA814490 - Sequence 374 from Patent EP2468898.
JA814988 - Sequence 374 from Patent EP2468899.
JA817231 - Sequence 374 from Patent EP2468892.
JA826043 - Sequence 374 from Patent EP2471956.
JA826541 - Sequence 374 from Patent EP2471958.
JB024828 - Sequence 374 from Patent EP2505668.
JB025326 - Sequence 374 from Patent EP2505669.
JB079713 - Sequence 374 from Patent EP2487252.
JB080211 - Sequence 374 from Patent EP2487253.
JB080709 - Sequence 374 from Patent EP2487254.
JB081207 - Sequence 374 from Patent EP2487255.
JB081705 - Sequence 374 from Patent EP2487256.
JB082203 - Sequence 374 from Patent EP2487257.
JB082701 - Sequence 374 from Patent EP2487258.
JB083199 - Sequence 374 from Patent EP2487259.
JB083697 - Sequence 374 from Patent EP2487260.
JB084195 - Sequence 374 from Patent EP2487261.
JB084693 - Sequence 374 from Patent EP2487262.
JB085191 - Sequence 374 from Patent EP2487263.
JB087869 - Sequence 374 from Patent EP2502630.
JB148073 - Sequence 374 from Patent EP2484782.
JB148571 - Sequence 374 from Patent EP2484783.
JB153296 - Sequence 374 from Patent EP2514433.
JB153794 - Sequence 374 from Patent EP2514434.
JB622383 - Sequence 374 from Patent EP2586454.
JB622881 - Sequence 374 from Patent EP2586455.
JC001944 - Sequence 374 from Patent EP2591794.
JC334102 - Sequence 20 from Patent EP2487240.
JE869374 - Sequence 15 from Patent WO2015131115.
LF636230 - JP 2016519076-A/4: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LG134387 - KR 1020150131312-A/4: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LY409570 - KR 1020160122850-A/15: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
MA264552 - JP 2017507955-A/15: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
DM175326 - A nucleics Acid regulating cell growth.
FW362670 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA.
FW363975 - Oligonucleotides for modulating target RNA activity.
HI377377 - Sequence 4 from Patent EP2087135.
HI539271 - Sequence 95 from Patent EP2160477.
HI965545 - Sequence 830 from Patent WO2010139812.
HI966146 - Sequence 466 from Patent WO2010139811.
HI967012 - Sequence 466 from Patent WO2010139810.
HV335766 - JP 2011093892-A/9: Tumor proliferation suppressor comprising tumor suppressive micro RNA.
HV515808 - JP 2011177139-A/1: A method for detecting cancer and a cancer-suppressing agent.
HV515809 - JP 2011177139-A/2: A method for detecting cancer and a cancer-suppressing agent.
HV515810 - JP 2011177139-A/3: A method for detecting cancer and a cancer-suppressing agent.
HV540982 - WO 2011125469-A/26: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV582952 - JP 2010527616-A/93: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HV593817 - JP 2010538610-A/30: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV594787 - JP 2010539959-A/168: Micromirs.
HW044137 - WO 2012161124-A/10: A composition comprising a miRNA or an expression system of said miRNA.
HW062431 - JP 2012530054-A/1: METHODS, SYSTEMS, AND COMPOSITIONS FOR NEURONAL DIFFERENTIATION OF MULTIPOTENT STROMAL CELLS.
HW120867 - WO 2013038737-A/30: Bladder cancer marker.
HW289777 - JP 2013520158-A/20: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW413642 - WO 2014003053-A/91: Method for screening pancreatic cancer and test kit therefor.
HZ043080 - JP 2015510401-A/170: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043081 - JP 2015510401-A/171: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043082 - JP 2015510401-A/172: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ043408 - JP 2015510401-A/498: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074080 - JP 2013535982-A/171: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081706 - JP 2015514392-A/170: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081707 - JP 2015514392-A/171: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ081708 - JP 2015514392-A/172: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ157344 - JP 2015130862-A/168: Micromirs.
HZ186288 - JP 2015146814-A/37: Oligonucleotides for modulating target RNA activity.
HZ392514 - JP 2015180203-A/20: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ432160 - JP 2014207909-A/93: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HZ479676 - JP 2015535430-A/182: TERMINALLY MODIFIED RNA.
HZ489617 - JP 2016020328-A/17: ANTICANCER AGENT.
HZ789607 - JP 2016504050-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401583 - Sequence 830 from Patent WO2011080318.
JA402561 - Sequence 830 from Patent WO2011080315.
JA403568 - Sequence 830 from Patent WO2011080316.
JA406199 - Sequence 830 from Patent EP2336353.
JA426979 - Sequence 312 from Patent WO2011072177.
JA429725 - Sequence 830 from Patent WO2011095623.
JA660646 - Sequence 100 from Patent WO2011131354.
JA667976 - Sequence 55 from Patent WO2011139911.
JB022310 - Sequence 152 from Patent WO2013026685.
JB022990 - Sequence 244 from Patent WO2013026684.
JB359245 - Sequence 1 from Patent EP2440660.
JB620256 - Sequence 236 from Patent WO2013063544.
JB835717 - Sequence 7 from Patent WO2013057567.
JC032816 - Sequence 88 from Patent WO2013160474.
JC037631 - Sequence 159 from Patent EP2643479.
JC512339 - Sequence 2592 from Patent WO2014113089.
JC529345 - Sequence 4 from Patent WO2014111892.
JC531658 - Sequence 78 from Patent WO2014082644.
JC583729 - Sequence 13 from Patent WO2014095922.
JC583737 - Sequence 21 from Patent WO2014095922.
JC605384 - Sequence 4 from Patent EP2757161.
JE978655 - Sequence 100 from Patent EP2865765.
LF128871 - JP 2016507218-A/2: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
LF161437 - JP 2016513950-A/1503: Oligomers with improved off-target profile.
LF404177 - JP 2015509366-A/170: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404178 - JP 2015509366-A/171: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404179 - JP 2015509366-A/172: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF404477 - JP 2015509366-A/470: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF857581 - JP 2015130879-A/30: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LG099946 - KR 1020150109407-A/4: miRNA-124 as a biomarker.
LP643475 - Sequence 4 from Patent WO2015041809.
LP714635 - Sequence 7 from Patent WO2015092707.
LP726772 - Sequence 466 from Patent EP2883966.
LP764390 - Sequence 1 from Patent WO2018051293.
LP819042 - Sequence 466 from Patent EP3296406.
LP909341 - Sequence 2 from Patent EP3214174.
LP931135 - Sequence 111 from Patent EP3224347.
LP938984 - Sequence 466 from Patent EP3184651.
LQ069927 - Sequence 251 from Patent EP2964234.
LQ500616 - Sequence 30 from Patent EP3048177.
LQ660986 - Sequence 7 from Patent EP3090058.
LQ724653 - Sequence 286 from Patent WO2018096084.
LV539139 - JP 2016539127-A/140: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LX282466 - JP 2016505268-A/4: miRNA-124 as a biomarker.
LY298541 - KR 1020160079824-A/140: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY404852 - KR 1020160117535-A/157: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY505011 - KR 1020170032361-A/4: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
LZ229982 - JP 2017522313-A/4: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
LZ233645 - JP 2017184756-A/37: Oligonucleotides for modulating target RNA activity.
MA149258 - JP 2018504093-A/111: INDUCED HEPATOCYTES AND USES THEREOF.
MA260091 - JP 2017505623-A/157: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA353708 - JP 2018075017-A/170: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA353709 - JP 2018075017-A/171: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA353710 - JP 2018075017-A/172: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MA354008 - JP 2018075017-A/470: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS673441 - Sequence 244 from Patent EP3135774.
MS834684 - Sequence 830 from Patent EP3112479.
MS901679 - Sequence 152 from Patent EP3156505.
MS904114 - Sequence 30 from Patent EP3138926.
MS930514 - Sequence 7 from Patent EP3178943.
CS166346 - Sequence 57 from Patent WO2005078096.
CS265322 - Sequence 64 from Patent EP1627925.
CS444377 - Sequence 64 from Patent WO2006108473.
DL231894 - Method for the determination of cellular transcriptional regulation.
AY940852 - Homo sapiens microRNA hsa-mir-RG-110, complete sequence.
FW363976 - Oligonucleotides for modulating target RNA activity.
HI965544 - Sequence 829 from Patent WO2010139812.
HI966190 - Sequence 510 from Patent WO2010139811.
HI967056 - Sequence 510 from Patent WO2010139810.
HV594788 - JP 2010539959-A/169: Micromirs.
HW044133 - WO 2012161124-A/6: A composition comprising a miRNA or an expression system of said miRNA.
HZ074079 - JP 2013535982-A/170: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ157345 - JP 2015130862-A/169: Micromirs.
HZ186289 - JP 2015146814-A/38: Oligonucleotides for modulating target RNA activity.
HZ479681 - JP 2015535430-A/187: TERMINALLY MODIFIED RNA.
HZ789612 - JP 2016504050-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401582 - Sequence 829 from Patent WO2011080318.
JA402560 - Sequence 829 from Patent WO2011080315.
JA403567 - Sequence 829 from Patent WO2011080316.
JA406198 - Sequence 829 from Patent EP2336353.
JA426928 - Sequence 261 from Patent WO2011072177.
JA429724 - Sequence 829 from Patent WO2011095623.
JA791745 - Sequence 147 from Patent WO2012089772.
JB022610 - Sequence 452 from Patent WO2013026685.
JB023179 - Sequence 433 from Patent WO2013026684.
JB175141 - Sequence 173 from Patent WO2012101219.
JB620255 - Sequence 235 from Patent WO2013063544.
JC512344 - Sequence 2597 from Patent WO2014113089.
JC529346 - Sequence 5 from Patent WO2014111892.
JC531657 - Sequence 77 from Patent WO2014082644.
JC605385 - Sequence 5 from Patent EP2757161.
LF128870 - JP 2016507218-A/1: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
LF160288 - JP 2016513950-A/354: Oligomers with improved off-target profile.
LG099947 - KR 1020150109407-A/5: miRNA-124 as a biomarker.
LP643474 - Sequence 3 from Patent WO2015041809.
LP726816 - Sequence 510 from Patent EP2883966.
LP769539 - Sequence 66 from Patent EP3294910.
LP819086 - Sequence 510 from Patent EP3296406.
LP909342 - Sequence 3 from Patent EP3214174.
LP939028 - Sequence 510 from Patent EP3184651.
LQ069932 - Sequence 256 from Patent EP2964234.
LX282467 - JP 2016505268-A/5: miRNA-124 as a biomarker.
LY404853 - KR 1020160117535-A/158: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY417028 - KR 1020160145093-A/134: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY505012 - KR 1020170032361-A/5: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
LZ229983 - JP 2017522313-A/5: QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES.
LZ233646 - JP 2017184756-A/38: Oligonucleotides for modulating target RNA activity.
MA260092 - JP 2017505623-A/158: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673630 - Sequence 433 from Patent EP3135774.
MS816789 - Sequence 138 from Patent WO2017085287.
MS834683 - Sequence 829 from Patent EP3112479.
MS901979 - Sequence 452 from Patent EP3156505.
MA643428 - JP 2017113010-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731312 - JP 2017140048-A/182: TERMINALLY MODIFIED RNA.
MA643433 - JP 2017113010-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731317 - JP 2017140048-A/187: TERMINALLY MODIFIED RNA.
MA400879 - JP 2018515097-A/66: Method for Diagnosis and Prognosis of Chronic Heart Failure.
LQ955699 - Sequence 30 from Patent EP2775001.
MA445701 - JP 2018138019-A/17627: Polycomb-Associated Non-Coding RNAs.
MP045454 - Sequence 276 from Patent EP3401394.
MP084124 - Sequence 276 from Patent EP3401393.
MP045348 - Sequence 170 from Patent EP3401394.
MP045349 - Sequence 171 from Patent EP3401394.
MP045350 - Sequence 172 from Patent EP3401394.
MP045648 - Sequence 470 from Patent EP3401394.
MP070427 - Sequence 24 from Patent WO2018231851.
MP084018 - Sequence 170 from Patent EP3401393.
MP084019 - Sequence 171 from Patent EP3401393.
MP084020 - Sequence 172 from Patent EP3401393.
MA800481 - JP 2018183181-A/1352: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800486 - JP 2018183181-A/1357: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA852125 - JP 2019022498-A/3: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
MA852124 - JP 2019022498-A/2: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
MA852123 - JP 2019022498-A/1: METHODS OF DIFFERENTIATING STEM CELLS BY MODULATING MIR-124.
MP264353 - Sequence 347 from Patent WO2019086603.
MP264354 - Sequence 348 from Patent WO2019086603.
MP280781 - Sequence 201 from Patent WO2019111197.
MP283694 - Sequence 201 from Patent WO2019111198.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029668
UCSC ID: uc003wsw.1
RefSeq Accession: NR_029668

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029668.1
exon count: 1CDS single in 3' UTR: no RNA size: 85
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 148.50frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.